T2D starts with the onset of insulin resistance, which is a cumulative health consequence of obesity, dysfunctional adipose tissue, chronic inflammation, and decrease in pancreatic β-cell mass and consecutive failure in the production of insulin. The gene discussed is INS; the disease is obesity disorder.